Literature DB >> 25676520

The treatment of rapidly growing mycobacterial infections.

Shannon H Kasperbauer1, Mary Ann De Groote2.   

Abstract

Rapidly growing mycobacteria (RGM) include a diverse group of species. We address the treatment of the most commonly isolated RGM-M abscessus complex, M fortuitum, and M chelonae. The M abscessus complex is composed of 3 closely related species: M abscessus senso stricto (hereafter M abscessus), M massiliense, and M bolletii. Most studies address treatment of M abscessus complex, which accounts for 80% of lung disease caused by RGM and is the second most common RGM to cause extrapulmonary disease (after M fortuitum). The M abscessus complex represent the most drug-resistant nontuberculous mycobacteria and are the most difficult to treat.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Antimicrobial therapy; Drug susceptibility testing; Mycobacterium abscessus; Mycobacterium massiliense; NTM lung diseases; Surgical therapy

Mesh:

Substances:

Year:  2014        PMID: 25676520     DOI: 10.1016/j.ccm.2014.10.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  28 in total

Review 1.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

2.  In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China.

Authors:  Yu Pang; Huiwen Zheng; Yaoju Tan; Yuanyuan Song; Yanlin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Shannon Novosad; Emily Henkle; Kevin L Winthrop
Journal:  Curr Pulmonol Rep       Date:  2015-07-12

4.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

5.  In Vitro Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus.

Authors:  Olumide Martins; Jin Lee; Amit Kaushik; Nicole C Ammerman; Kelly E Dooley; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

6.  Mycobacterium abscessus Infections in Solid Organ Transplant Recipients: Single-Center Experience in the United States, 2013-2018.

Authors:  Yosuke Ebisu; Yoichiro Natori; Gemma Rosello; Shweta Anjan; Jacques Simkins; Jose F Camargo; Michele I Morris; Octavio V Martinez; Lilian M Abbo
Journal:  Open Forum Infect Dis       Date:  2022-05-18       Impact factor: 4.423

7.  Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease.

Authors:  Keiji Fujiwara; Koji Furuuchi; Akio Aono; Fumiko Uesugi; Tatsuya Shirai; Keitaro Nakamoto; Takafumi Shimada; Fumi Mochizuki; Yoshiaki Tanaka; Hiroaki Iijima; Takashi Yoshiyama; Yuji Shiraishi; Atsuyuki Kurashima; Ken Ohta; Satoshi Mitarai; Kozo Morimoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-01       Impact factor: 3.267

8.  Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Getahun Abate; Jack T Stapleton; Nadine Rouphael; Buddy Creech; Jason E Stout; Hana M El Sahly; Lisa Jackson; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Nora Watson; Aaron Miller; Edward Charbek; Joan Siegner; Marcia Sokol-Anderson; Ravi Nayak; Greta Dahlberg; Pat Winokur; Ghina Alaaeddine; Nour Beydoun; Katherine Sokolow; Naomi Prashad Kown; Shanda Phillips; Arthur W Baker; Nicholas Turner; Emmanuel Walter; Elizabeth Guy; Sharon Frey
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 20.999

Review 9.  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives.

Authors:  Yon Ju Ryu; Won-Jung Koh; Charles L Daley
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-03-31

10.  Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.

Authors:  Su-Young Kim; Sung Jae Shin; Byeong-Ho Jeong; Won-Jung Koh
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.